Scott Dreyer - Net Worth and Insider Trading

Scott Dreyer Net Worth

The estimated net worth of Scott Dreyer is at least $2 Million dollars as of 2026-09-12. Scott Dreyer is the EVP & Chief Commercial Officer of Collegium Pharmaceutical Inc and owns about 71,770 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $2 Million. Details can be seen in Scott Dreyer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Dreyer has not made any transactions after 2026-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Scott Dreyer

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Scott Dreyer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Dreyer owns 1 companies in total, including Collegium Pharmaceutical Inc (COLL) .

Click here to see the complete history of Scott Dreyer’s form 4 insider trades.

Insider Ownership Summary of Scott Dreyer

Ticker Company Transaction Date Type of Owner
COLL Collegium Pharmaceutical Inc 2026-03-03 EVP & Chief Commercial Officer

Scott Dreyer Latest Holdings Summary

Scott Dreyer currently owns a total of 1 stock. Scott Dreyer owns 71,770 shares of Collegium Pharmaceutical Inc (COLL) as of March 3, 2026, with a value of $2 Million.

Latest Holdings of Scott Dreyer

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COLL Collegium Pharmaceutical Inc 2026-03-03 71,770 22.74 1,631,691

Holding Weightings of Scott Dreyer


Scott Dreyer Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Dreyer has made a total of 15 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 49,976 shares on March 3, 2026, which brought Scott Dreyer around $2 Million.

Insider Trading History of Scott Dreyer

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Dreyer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Scott Dreyer owns.
View COLL Analysis

Scott Dreyer Ownership Network

Ownership Network List of Scott Dreyer

No Data

Ownership Network Relation of Scott Dreyer

Insider Network Chart


Scott Dreyer Owned Company Details

What does Collegium Pharmaceutical Inc do?

Who are the key executives at Collegium Pharmaceutical Inc?

Scott Dreyer is the EVP & Chief Commercial Officer of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP & General Counsel David Dieter , EVP & Chief Financial Officer Tupper Colleen , and EVP and Chief Medical Officer Thomas B Smith .

Collegium Pharmaceutical Inc (COLL) Insider Trades Summary

Over the past 18 months, Scott Dreyer made 6 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 111,889. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 22,407 shares made by John Gordon Freund , a net sale of 38,579 shares made by Tupper Colleen , and a net sale of 20,200 shares made by David Dieter .

In summary, during the past 3 months, insiders sold 0 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 292,661 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 292,661 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Collegium Pharmaceutical Inc Insider Transactions

No Available Data

Scott Dreyer Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Dreyer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Scott Dreyer's mailing address is: Canton Ma 02021.